Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
- Status
- TERMINATED
- Phase
- PHASE2
Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
- Status
- UNKNOWN
- Phase
- PHASE3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
- Status
- COMPLETED
- Phase
- PHASE3
Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE3